Showing results (71-80 of 279) with videos related to

Sort By:
Pageof 28
Pediatric Transplantation|November 3, 2007
Cold agglutinin syndrome in pediatric liver transplant recipientsWendy Wong, Jason D Merker, Christine Nguyen, et al.
American Journal of Hematology|November 14, 2008
A Phase II intra-patient dose-escalation trial of weight-based darbepoetin alfa with or without granulocyte-colony stimulating factor in myelodysplastic syndromesJason Gotlib, Philip Lavori, Sylvia Quesada, et al.
Expert Opinion on Biological Therapy|October 16, 2020
Practical management of adverse events in patients with advanced systemic mastocytosis receiving midostaurinJason Gotlib, Hanneke C Kluin-Nelemans, Cem Akin, et al.
Expert Review of Hematology|October 3, 2013
Practical management of patients with myelofibrosis receiving ruxolitinibClaire Harrison, Ruben Mesa, David Ross, et al.
Genome Research|December 15, 2016
Reconstructing genetic history of Siberian and Northeastern European populationsEmily H M Wong, Andrey Khrunin, Larissa Nichols, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2014
Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutationsRobert S Ohgami, Lisa Ma, Jason D Merker, et al.
The Journal of Molecular Diagnostics : JMD|July 11, 2006
Detection of the JAK2 V617F mutation by LightCycler PCR and probe dissociation analysisMarla Lay, Rajan Mariappan, Jason Gotlib, et al.
Archives of Pathology & Laboratory Medicine|March 14, 2019
Next-Generation Sequencing (NGS) Methods Show Superior or Equivalent Performance to Non-NGS Methods on <i>BRAF</i>, <i>EGFR</i>, and <i>KRAS</i> Proficiency Testing SamplesLea F Surrey, Fredrick D Oakley, Jason D Merker, et al.
Archives of Pathology & Laboratory Medicine|July 9, 2016
A Model Study of In Silico Proficiency Testing for Clinical Next-Generation SequencingEric J Duncavage, Haley J Abel, Jason D Merker, et al.
Blood|April 9, 2004
The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and managementJason Gotlib, Jan Cools, James M Malone, et al.
Pageof 28